Amniotic Mesenchymal Stem Cells Decrease A β Deposition and Improve Memory in APP/PS1 Transgenic Mice.

In conclusion, our data suggest that hAM-MSCs may be a new and effective therapy for the treatment of AD.
PMID: 28397068 [PubMed - as supplied by publisher]

Source: Neurochemical Research - April 10, 2017 Category: Neuroscience Authors: Zheng XY, Wan QQ, Zheng CY, Zhou HL, Dong XY, Deng QS, Yao H, Fu Q, Gao M, Yan ZJ, Wang SS, You Y, Lv J, Wang XY, Chen KE, Zhang MY, Xu RX Tags: Neurochem Res Source Type: research